Armistice Capital »

Applied Therapeutics shares owned by Armistice Capital

Quarter-by-quarter ownership of Applied Therapeutics (APLT) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Applied Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Applied Therapeutics held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Applied Therapeutics by Armistice Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $8.5M 3.4M 2.49

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Argenx Se Sponsored Adr (ARGX)
Supernus Pharmaceuticals (SUPN)
Ptc Therapeutics I (PTCT)
Neurocrine Biosciences (NBIX)
Agios Pharmaceuticals (AGIO)
Biogen Idec (BIIB)
Colgate-Palmolive Company (CL)
Travere Therapeutics (TVTX)
Nevro (NVRO)
Amazon (AMZN)
Dentsply Sirona (XRAY)
Regeneron Pharmaceuticals (REGN)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Armistice Capital

Top funds holding Applied Therapeutics

Alyeska Investment Group
Franklin Resources
VR Adviser
Knoll Capital Management
Propel Bio Management
Perceptive Advisors
Vanguard Group
Simplify Asset Management
Henderson Group
Logos Global Management
AIGH Capital Management
Opaleye Management
Millennium Management
Schonfeld Strategic Advisors
Point72 Asset Management

View all funds holding Applied Therapeutics